1. A human arterial transcriptomic signature predicts major adverse cardiac events and identifies novel, redox-related therapeutic targets within the vascular wall. (14th October 2021) Authors: Kotanidis, C P; Lockstone, H; Polkinghorne, M; Badi, I; Akoumianakis, I; Siddique, M; Antonopoulos, A; Evans, T; Farid, S; Srivastava, V; Krasopoulos, G; Sayeed, R; Channon, K M; Antoniades, C Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Constructing custom-made radiotranscriptomic signatures from CT angiograms: an application in COVID-19 vascular inflammation. (3rd October 2022) Authors: Kotanidis, C P; Xie, C; Siddique, M; Burnham, K; Lockstone, H; Kotronias, R; West, H; Rodrigues, J; Adlam, D; Neubauer, S; Channon, K; Deanfield, J; Ho, L P; Antoniades, C Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. S77 Transcriptomic studies reveal monocyte-related genes as major contributor to disease activity in pulmonary sarcoidosis. (15th November 2017) Authors: Kendrick, Y; Crawshaw, A; Lockstone, H; Giannoulatou, E; Argoud, K; Taylor, S; Ho, LP Journal: Thorax Issue: Volume 72(2017)Supplement 3 Page Start: A48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗